Global Non-Opioid Pain Relief Device Market

Global Non-Opioid Pain Relief Device Market:

Focus on Application, Technology, End-User, Competitive Landscape – Analysis and Forecast, 2018-2029

In 2018, the global non-opioid pain relief device market was estimated to be $3,674 million and it is expected to reach a value of $8,778.9 million by the end of 2029..

SKU: BH148A
Published Year: 2019
 

Key Questions Answered in this Report:

•    What are the major non-opioid pain relief devices available within the market and what are their benefits?
•    What are the major drivers, challenges, and opportunities in the global non-opioid pain relief device market? 
•    What are the key developmental strategies implemented by the key players to stand out in this market? 
•    How is the industry anticipated to evolve during the forecast period 2019-2029? 
•    Which region is expected to contribute to the highest sales of the global non-opioid pain relief device market during the forecast period? 
•    What are the leading trends and consumer preferences witnessed in global non-opioid pain relief device market?

Overview of the Global Non-Opioid Pain Relief Device Market

The rising trend of sedentary lifestyle and growing geriatric population have led to the emergence of chronic pain disorders. Multiple chronic pain conditions including neurological and musculoskeletal disorders act as leading contributors for the global non-opioid pain relief device market. These factors have become the primary drivers for the non-opioid pain relief device market. The market is further expected to proliferate at a rapid pace owing to the increased side effects of opioid medications for pain management, that further promote the early adoption of non-opioid pain relief medical devices among people of all age groups. Moreover, a limited success rate of drugs targeting a specific disease is further facilitating the growth of the market.

Global Non-Opioid Pain Relief Device Market Forecast (2019-2029)

In 2018, the global non-opioid pain relief device market was estimated to be $3,674 million and it is expected to reach a value of $8,778.9 million by the end of 2029. The market is primarily driven by increasing government regulations and higher incidences of chronic pain.

The overall global non-opioid pain relief device market has witnessed a steady growth. The market is expected to continue to grow with a CAGR of 8.26% during the forecast period 2019-2029. However, limited products available and limited awareness regarding them act as challenges that may affect the steady growth of the market

Expert Quote

“North America held the largest market share in 2018 and constitutes over 39.5% of the revenue share owing to increased incidences of chronic pain as well as higher proliferation of regulations and standards in different parts of the world. However, Asia-Pacific is projected to be the fastest-growing region and is anticipated to grow at a CAGR of over 9.9% from 2019 to 2029.”

Scope of the Global Non-Opioid Pain Relief Device Market Report 

The report presents the reader with an opportunity to unlock comprehensive insights with respect to the market and uncover some of the substantial parameters that must be taken into consideration before entering the market.

The report further takes into consideration the market dynamics and the competitive landscape along with the detailed financial and product contribution of the key players operating in the market. The Global Non-Opioid Pain Relief Device Market report is a compilation of different segments including market breakdown by application, technology, end-user, and region. 

Market Segmentation

The global non-opioid pain relief device market segmentation is majorly done on the basis of application and technology. The application section was further segmented into neuromuscular, musculoskeletal, diabetic neuropathy, injuries and others. The neuromuscular segment dominated the global non-opioid pain relief device market, accounting for around 37.4% of the total market in 2018 and is anticipated to maintain its dominance throughout the forecast period. The other segments within the market are also estimated to witness steady growth rate in the forecast period due to surge in geriatric population worldwide and stringent regulations pertaining to opioid usage.

The global non-opioid pain relief device market segmentation is done on the basis of technology, and it is further segmented into Electroanalgesia, Radiofrequency Ablation and Other Emerging Technologies. The Electroanalgesia segment comprises multiple technologies and dominates the market with a share of 90.1%. The Radiofrequency ablation and other emerging technologies have a share of 9.7% and 0.2% respectively in the global non-opioid pain relief device market. The increased funding in research and development sector by leading companies and by government institutions have led to the advancement in the technologies and also in the associated market.

The global non-opioid pain relief device market segmentation by region is done into North America, Europe, APAC, Latin America and Middle East and Africa. North America dominated the global non-opioid pain relief device market accounting for 39.5% of the total market share in 2018 and is anticipated to uphold its dominance throughout the forecast period. The global non-opioid pain relief device market was estimated to have 1,452.6 million market in 2018. However, the highest growth rate of 9.9% is expected to be witnessed by the APAC region in the forecast period of 2019-2029. 

Key Companies in the Global Non-Opioid Pain Relief Device Market

The key players in the global non-opioid pain relief device market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Koninklijke Philips N.V., Stryker, Nuvectra Corporation, Omron Corporation, Neurometrix, Inc, Calmare Therapeutics Incorporated, Bayer AG, Bioelectronics Corporation, Zynex Medical, SPR Therapeutics, AAND Stimwave LLC, Thermotek Inc.

   Executive Summary
   1    Market Overview
         1.1    Pain Management Overview
         1.2    Pain Management by Usage of Opioid Drugs
         1.3    Pain Management by Usage of Non-Opioid Drugs and Devices
         1.4    Evolution of Pain Relief Devices
         1.5    Factors Propelling the Market Growth
         1.6    Classification of Non-Opioid Pain Relief Devices Market
         1.7    Potential Benefits and Risks of Non-Opioid Pain Relief Devices
         1.8    Market Limitations and Assumptions
 
   2    Market Dynamics
         2.1    Overview
         2.2    Market Drivers
                  2.2.1    Increase in Pain Incidences in Geriatric Population
                  2.2.2    Advent of Sedentary Lifestyle Leading to Increased Burden of Chronic Pain
                  2.2.3    Limited success Rate of Drugs Targeting Pain Disorders
                  2.2.4    High Number of Side Effects of the Opioid Drugs
         2.3    Market Restraints
                  2.3.1    Insufficient Number of Long-Term Clinical Studies
                  2.3.2    Low Number of Pain Specialists Worldwide
                  2.3.3    Burden of Product Recalls
                  2.3.4    Limited Awareness Regarding Products Available
         2.4    Market Trends
                  2.4.1    Shift of Demand Toward Wearable Technology
                  2.4.2    Miniaturization and Technological Advancement in the Pain Relief Technologies
                  2.4.3    Emergence of Minimally Invasive Therapies for Pain Relief
                  2.4.4    Non-Opioid Treatment for Pain Over Opioid Therapies
 
   3    Competitive Landscape
         3.1    Key Strategies and Developments
         3.2    Key Strategies and Developments
                  3.2.1    Product Launches
                  3.2.2    Collaborations, Joint Ventures, and Partnerships
                  3.2.3    Awards and Recognitions
                  3.2.4    Mergers and Acquisitions
         3.3    Market Share Analysis
                  3.3.1    Market Share Analysis (by Company)
         3.4    Market Share Analysis (by Country)
         3.5    Industry Attractiveness (Porter’s Five Forces Analysis)
                  3.5.1    Bargaining Power of Suppliers
                              3.5.1.1    Supplier to Firm Concentration Ratio
                              3.5.1.2    Presence of Brands
                              3.5.1.3    Degree of Product Differentiation
                              3.5.1.4    Threat of Forward Integration
                  3.5.2    Bargaining Power of Buyers
                              3.5.2.1    Buyer to Firm Concentration Ratio
                              3.5.2.2    Presence of Substitutes
                              3.5.2.3    Dependence on Distribution Channels
                              3.5.2.4    Buyer Information About Products
                  3.5.3    Threat of New Entrants
                              3.5.3.1    Regulatory Landscape
                              3.5.3.2    Brand Visibility
                              3.5.3.3    Product Differentiation
                              3.5.3.4    Capital Investments and Funding
                  3.5.4    Threat of Substitutes
                              3.5.4.1    Buyers’ Propensity toward Substitutes
                              3.5.4.2    Availability of Substitutes
                              3.5.4.3    Perceived Level of Product Differentiation
                   3.5.5    Intensity of Competitive Rivalry
                               3.5.5.1    Customer’s Loyalty Toward the Brand Image
                               3.5.5.2    Entry Barriers Through Innovations
                               3.5.5.3    Power of Competitive Strategy
         3.6    Industry Insights
                  3.6.1 Regulatory Organizations/ Associations/ Consortiums
 
   4    Global Non-Opioid Pain Relief Device Market (By Application)
         4.1    Overview
         4.2    Neuromuscular Pain
         4.3    Musculoskeletal Pain
         4.4    Injuries
         4.5    Diabetic Neuropathy
         4.6    Others
 
   5    Global Non-Opioid Pain Relief Device Market (by Technology)
         5.1    Overview
         5.2    Electroanalgesia
                  5.2.1    Implantable Device
                  5.2.2    Non-Implantable Device
                              5.2.2.1    Traditional TENS
                              5.2.2.2    Wearable TENS
                              5.2.2.3    Others
         5.3    Radiofrequency Ablation
         5.4    Other Emerging Technologies
 
   6    Global Non-Opioid Pain Relief Device Market (by End User)
         6.1    Overview
         6.2    Hospitals
         6.3    Pain Management Centers
         6.4    Homecare
 
   7    Global Non-Opioid Pain Relief Device Market (by Region)
         7.1    Overview
         7.2    North America Non-Opioid Pain Relief Device Market
                  7.2.1    North America Non-Opioid Pain Relief Device Market, 2018-2029, $Million
                  7.2.2    North America Non-Opioid Pain Relief Device Market (by Application),  2018-2029, $Million
                  7.2.3    North America Non-Opioid Pain Relief Device Market (by Technology), 2018-2029, $Million
                  7.2.4    North America Non-Opioid Pain Relief Device Market (by End User), 2018-2029, $Million
                  7.2.5    North America Non-Opioid Pain Relief Device Market (by Country), 2018-2029, $Million
                  7.2.6    North America Non-Opioid Pain Relief Device Market (by Country), 2018-2029, $Million
                              7.2.6.1    The U.S.
                              7.2.6.2    Canada
         7.3    Europe Non-Opioid Pain Relief Device Market
                  7.3.1    Europe Non-Opioid Pain Relief Device Market, 2018-2029, $Million
                  7.3.2    Europe Non-Opioid Pain Relief Device Market (by Application), 2018-2029, $Million
                  7.3.3    Europe Non-Opioid Pain Relief Device Market (by Technology), 2018-2029, $Million
                  7.3.4    Europe Non-Opioid Pain Relief Device Market (by Country), 2018-2029, $Million
                              7.3.4.1    The U.K.
                              7.3.4.2    Germany
                              7.3.4.3    Italy
                              7.3.4.4    France
                              7.3.4.5    Netherlands
                              7.3.4.6    Spain
                              7.3.4.7    Rest of Europe
         7.4    Asia Pacific Non-Opioid Pain Relief Device Market
                  7.4.1    Asia-Pacific Non-Opioid Pain Relief Device Market, 2018-2029, $Million
                  7.4.2    Asia-Pacific Non-Opioid Pain Relief Device Market (by Application), 2018-2029, $Million
                  7.4.3    Asia-Pacific Non-Opioid Pain Relief Device Market (by Technology), 2018-2029, $Million
                  7.4.4    Asia-Pacific Non-Opioid Pain Relief Device Market (by Country), 2018-2029, $Million
                              7.4.4.1    China
                              7.4.4.2    India
                              7.4.4.3    Japan
                              7.4.4.4    Australia
                              7.4.4.5    New Zealand
                              7.4.4.6    Rest-of-Asia-Pacific
         7.5    Latin America Non-Opioid Pain Relief Device Market
                  7.5.1    Latin America Non-Opioid Pain Relief Device Market, 2018-2029, $Million
                  7.5.2    Latin America Non-Opioid Pain Relief Device Market (By Application), 2018-2029, $Million
                  7.5.3    Latin America Non-Opioid Pain Relief Device Market (By Technology), 2018-2029, $Million
                  7.5.4    Latin America Non-Opioid Pain Relief Device Market (by End User), 2018-2029, $Million
                  7.5.5    Latin America Non-Opioid Pain Relief Device Market (by Country),  2018-2029, $Million
                              7.5.5.1    Brazil
                              7.5.5.2    Mexico
                              7.5.5.3    Rest-of-Latin America
         7.6    Middle East and Africa Non-Opioid Pain Relief Device Market, 2018-2029, $Million
                  7.6.1    Middle East and Africa Non-Opioid Pain Relief Device Market, 2018-2029, $Million
                  7.6.2    Middle East and Africa Non-Opioid Pain Relief Device Market (By Application), 2018-2029, $Million
                  7.6.3    Middle East and Africa Non-Opioid Pain Relief Device Market (By Technology), 2018-2029, $Million
                  7.6.4    Middle East and Africa Non-Opioid Pain Relief Device Market (by End User), 2018-2029, $Million
                  7.6.5    Middle East and Africa Non-Opioid Pain Relief Device Market (By Country), 2018-2029, $Million
                              7.6.5.1    Kingdom of Saudi Arabia
                              7.6.5.2    South Africa
                              7.6.5.3    Rest-of-Middle East and Africa
 
   8    Company Profiles
         8.1    Overview
         8.2    Abbott Laboratories
                  8.2.1    Company Overview
                  8.2.2    Role of Abbott Laboratories in the Global Non-Opioid Pain Relief Devices Market
                  8.2.3    Financials
                  8.2.4    SWOT Analysis
         8.3    Bayer AG
                  8.3.1    Company Overview
                  8.3.2    Role of Bayer AG in the Global Non-opioid pain relief device Market
                  8.3.3    Financials
                  8.3.4    SWOT Analysis
         8.4    Bioelectronics Corporation
                  8.4.1    Company Overview
                  8.4.2    Role of Bioelectronics Corporation in the Global Non-Opioid Pain Relief Devices Market
                  8.4.3    Financials
                  8.4.4    SWOT Analysis
         8.5    Boston Scientific Corporation
                  8.5.1    Company Overview
                  8.5.2    Financials
                  8.5.3    SWOT Analysis
         8.6    Medtronic plc
                  8.6.1    Company Overview
                  8.6.2    Role of Medtronic plc in the Non-Opioid Pain Relief Devices Market
                  8.6.3    Financials
                  8.6.4    Key Insights about Financial Health of the Company
                  8.6.5    SWOT Analysis
         8.7    Koninklijke Philips N.V.
                  8.7.1    Company Overview
                  8.7.2    Role of Koninklijke Philips N.V. in the Global non-opioid pain relief device Market
                  8.7.3    Financials
                  8.7.4    SWOT Analysis
         8.8    NeuroMetrix Inc.
                  8.8.1    Company Overview
                  8.8.2    Role of NeuroMetrix, Inc. in the Non-Opioid Pain Relief Devices Market
                  8.8.3    Financials
                  8.8.4    SWOT Analysis
         8.9    Nuvectra Corporation
                  8.9.1    Company Overview
                  8.9.2    Role of Nuvectra Corporation in the Global Non-Opioid Pain relief Device Market
                  8.9.3    Financials
                  8.9.4    SWOT Analysis
        8.10   Omron Corporation
                  8.10.1    Company Overview
                  8.10.2    Role of Omron Corporation in the Global Non-Opioid Pain Relief Device Market
                  8.10.3    Financials
                  8.10.4    SWOT Analysis
        8.11   Stryker Corporation
                  8.11.1    Company Overview
                  8.11.2    Role of Stryker Corporation in the Global Non-Opioid Pain Relief Device Market
                  8.11.3    Financials
                  8.11.4    SWOT Analysis
        8.12   SPR Therapeutics, LLC
                  8.12.1    Company Overview
                  8.12.2    Role of SPR Therapeutics, LLC in the Global Non-Opioid Device Market
                  8.12.3    SWOT Analysis
        8.13   Stimwave LLC
                  8.13.1    Company Overview
                  8.13.2    Role of Stimwave LLC in the Global Non-Opioid Device Market
                  8.13.3    SWOT Analysis
        8.14   Thermotek Inc.
                  8.14.1    Company Overview
                  8.14.2    Role of Thermotek Inc. in the Global Non-Opioid Device Market
                  8.14.3    SWOT Analysis
        8.15   Zynex Medical
                  8.15.1    Company Overview
                  8.15.2    Role of Zynex Medical in the Global Non-Opioid Device Market
                  8.15.3    Financials
                  8.15.4    SWOT Analysis
 
   9    Research Scope and Methodology
         9.1    Report Scope
         9.2    Global Non-Opioid Pain Relief Device Market: Research Methodology
                  9.2.1    Primary Data Sources
                  9.2.2    Secondary Data Sources
                  9.2.3    Data Triangulation
         9.3    Data and Prediction Modeling
 

List of Tables

Table 1:    Impact of Market Drivers, 2018-2029
Table 2:    Impact of Market Restraints, 2018-2029
Table 1.1:    List of Non-Opioids Pain Relief Drugs*
Table 1.2:    List of Non-Opioid Pain Relief Medical Devices*
Table 2.1:    Global Mortality Census Post Opioid Usage Disorder (Year – 2015)
Table 2.2:    Market Drivers: Impact Analysis
Table 2.3:    Market Restraints: Impact Analysis
Table 3.1:    Regulatory Bodies Related to Non-Opioid Pain Relief Devices (by Country)

List of Figures

Figure 1:    Global Non-Opioid Pain Relief Device Market (by Application), 2018 and 2029
Figure 2:    Global Non-Opioid Pain Relief Device Market (by Technology), 2018 and 2029
Figure 3:    Global Non-Opioid Pain Relief Device Market (by End User), 2018 and 2029
Figure 4:    Global Non-Opioid Pain Relief Device Market (by Region), 2019- 2029
Figure 5:    Key Strategies Incorporated by the key Players in the Global Non-Opioid Pain Relief Device Market (January 2019 – April 2029)
Figure 6:    Market Share Analysis for the Global Non-Opioid Pain Relief Device Market (by Company) (2018)
Figure 1.1:    Global Non-Opioid Pain Relief Device Market, 2018-2029, $Million
Figure 2.1:    Global Non-Opioid Pain Relief Device Market Dynamics
Figure 3.1:    Share of Key Developments and Strategies, January 2016 -February 2019
Figure 3.2:    Product Launches (by Company), January 2017-February 2019
Figure 3.3:    Collaborations and Partnerships (by Company), January 2015-February 2019
Figure 3.4:    Awards and Recognition (by Company), January 2015-February 2019
Figure 3.5:    Mergers and Acquisitions Share (by Company), January 2015-February 2019
Figure 3.6:    Market Share Analysis for the Global Non-Opioid Pain Relief Device Market, by Company (2018)
Figure 3.7:    Market Share Analysis for the Global Non-Opioid Pain Relief Device Market (by Country) (2018 and 2029)
Figure 3.8:    Industry Attractiveness (Porter’s Five Forces Analysis)
Figure 3.9:    Analysis of Bargaining Power of Suppliers, 2018 and 2029
Figure 3.10    : Analysis of Bargaining Power of Buyers, 2018 and 2029
Figure 3.11    : Analysis of Threat of New Entrants, 2018 and 2029
Figure 3.12    : Analysis of Threat of Substitutes, 2018 and 2029
Figure 3.13    : Analysis of Intensity of Competitive Rivalry, 2018 and 2029
Figure 4.1:    Global Non-Opioid Pain Relief Device Market (By Application), 2018-2029, $Million
Figure 4.2:    Global Non-Opioid Pain Relief Device Market (Neuromuscular Pain), 2018-2029, $Million
Figure 4.3:    Global Non-Opioid Pain Relief Device Market (Musculoskeletal Pain), 2018-2029, $Million
Figure 4.4:    Global Non-Opioid Pain Relief Device Market (Injuries), 2018-2029, $Million
Figure 4.5:    Global Non-Opioid Pain Relief Device Market (Diabetic Neuropathy), 2018-2029, $Million
Figure 4.6:    Global Non-Opioid Pain Relief Device Market (Other Pain), 2018-2029, $Million
Figure 5.1:    Global Non-Opioid Pain Relief Device Market (by Technology), 2018-2029, $Million
Figure 5.2:    Global Non-Opioid Pain Relief Device Market (Electroanalgesia), 2018-2029, $Million
Figure 5.3:    Global Non-Opioid Pain Relief Device Market (By Electroanalgesia Technology), 2018 and 2029
Figure 5.4:    Global Non-Opioid Pain Relief Device Market (Implantable Device), 2018-2029, $Million
Figure 5.5:    Market Share Analysis of Key Players in the Implantable Pain Relief Device Market, $Million
Figure 5.6:    Fragmentation of Non-Implantable Electroanalgesia Technologies- TENS, 2018 and 2029
Figure 5.7:    Global Non-Opioid Pain Relief Device Market (Traditional TENS), 2018-2029, $Million
Figure 5.8:    Market Share Analysis of Key Players in the Traditional TENS Device Market, $Million
Figure 5.9:    Global Non-Opioid Pain Relief Device Market (Wearable TENS), 2018-2029, $Million
Figure 5.10:    Market Share Analysis of Key Players in the Wearable TENS Device Market, $Million
Figure 5.11:    Global Non-Opioid Pain Relief Device Market (Others), 2018-2029, $Million
Figure 5.12:    Global Non-Opioid Pain Relief Device Market (Radiofrequency Ablation), 2018-2029, $Million
Figure 5.13:    Market Share Analysis of Key Players in Radiofrequency Ablation Device Market, $Million
Figure 5.14:    Global Non-Opioid Pain Relief Device Market (Other Emerging Technologies), 2018-2029, $Million
Figure 6.1:    Global Non-Opioid Pain Relief Device Market (by End User), 2018-2029, $Million
Figure 6.2:    Global Non-Opioid Pain Relief Devices Market (by Hospitals), 2018-2029, $Million
Figure 6.3:    Global Non-Opioid Pain Relief Devices Market (by Pain Management Centres), 2018-2029, $Million
Figure 6.4:    Global Non-Opioid Pain Relief Devices Market (by Homecare), 2018-2029, $Million
Figure 7.1:    Global Non-Opioid Pain Relief Device Market Scenario (by Region), 2018 and 2029, $Million
Figure 7.2:    North America Non-Opioid Pain Relief Device Market Scenario, 2018-2029, $Million
Figure 7.3:    North America Non-Opioid Pain Relief Device Market Scenario (By Application), 2018 and 2029, $Million
Figure 7.4:    North America Non-Opioid Pain Relief Device Market Scenario (by Application), 2018 and 2029, $Million
Figure 7.5:    North America Non-Opioid Pain Relief Device Market Scenario (by End User), 2018 and 2029, $Million
Figure 7.6:    North America Non-Opioid Pain Relief Device Market Scenario (by Country), 2018 and 2029, $Million
Figure 7.7:    U.S. Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
Figure 7.8:    Canada Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
Figure 7.9:    Europe Non-Opioid Pain Relief Device Market Scenario, 2018 and 2029, $Million
Figure 7.10:    Europe Non-Opioid Pain Relief Device Market, (By Application), 2018 and 2029, $Million
Figure 7.11:    Europe Non-Opioid Pain Relief Device Market Scenario (By Technology), 2018 and 2029, $Million
Figure 7.12:    Europe Non-Opioid Pain Relief Device Market Scenario (by Country), 2018 and 2029, $Million
Figure 7.13:    The U.K. - Non-Opioid Pain Relief Device Market, 2018-2029, $Million
Figure 7.14:    Germany- Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
Figure 7.15:    Italy-Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
Figure 7.16:    France- Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
Figure 7.17:    Netherlands- Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
Figure 7.18:    Spain- Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
Figure 7.19:    Rest of Europe Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
Figure 7.20:    Asia-Pacific Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
Figure 7.21:    Asia-Pacific Non-Opioid Pain Relief Device Market Scenario (by Application), 2018 and 2029, $Million
Figure 7.22:    Asia-Pacific Non-Opioid Pain Relief Device Market Scenario (by Technology), 2018 and 2029, $Million
Figure 7.23:    Asia-Pacific Non-Opioid Pain Relief Device Market Scenario (by Country), 2018 and 2029, $Million
Figure 7.24:    China Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
Figure 7.25:    India Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
Figure 7.26:    Japan Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
Figure 7.27:    Australia Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
Figure 7.28:    New Zealand Non-Opioid Pain Relief Device Market, 2018-2029, $Million
Figure 7.29:    Rest-of-Asia-Pacific Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
Figure 7.30:    Latin America Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
Figure 7.31:    Latin America Non-Opioid Pain Relief Device Market Scenario (by Application), 2018 and 2029, $Million
Figure 7.32:    Latin America Non-Opioid Pain Relief Device Market (by Technology), 2018 and 2029, $Million
Figure 7.33:    Latin America Non-Opioid Pain Relief Device Market (by End User), 2018 and 2029, $Million
Figure 7.34:    Latin America Non-Opioid Pain Relief Device Market (By Country), 2018 and 2029, $Million
Figure 7.35:    Brazil Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
Figure 7.36:    Mexico Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
Figure 7.37:    Rest-of-Latin America Non-Opioid Pain Relief Device Market,  2018- 2029, $Million
Figure 7.38:    Middle East and Africa Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
Figure 7.39:    Middle East and Africa Non-Opioid Pain Relief Device Market (By Application), 2018 and 2029, $Million
Figure 7.40:    Middle East and Africa Non-Opioid Pain Relief Device Market Scenario (By Technology), 2018 and 2029, $Million
Figure 7.41:    Middle East and Africa Non-Opioid Pain Relief Device Market (By End-user), 2018 and 2029, $Million
Figure 7.42:    Middle East and Africa Non-Opioid Pain Relief Device Market (by Country), 2018 and 2029, $Million
Figure 7.43:    Kingdom of Saudi Arabia Non-Opioid Pain Relief Device Market, 2018 and 2029, $Million
Figure 7.44:    South Africa Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
Figure 7.45:    South Africa Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
Figure 8.1:    Total Number of Companies Profiled
Figure 8.2:    Abbott Laboratories: Overall Product Portfolio for Global Non-opioid Pain Relief Device Market
Figure 8.3:    Abbott Laboratories: Overall Financials, 2016-2018
Figure 8.4:    Abbott Laboratories: Revenue (by Segment), 2016-2018
Figure 8.5:    Abbott Laboratories: Revenue (by Region), 2016-2018
Figure 8.6:    Abbott Laboratories: R&D Expenditure, 2016-2018
Figure 8.7:    Abbott Laboratories: SWOT Analysis
Figure 8.8:    Bayer AG - Product Portfolio for Global Non-Opioid Pain Relief Device Market
Figure 8.9:    Bayer AG - Overall Financials, 2016-2018
Figure 8.10:    Bayer AG - Revenue (by Segment), 2016-2018
Figure 8.11:    Bayer AG - Revenue (by Region), 2016-2018
Figure 8.12:    Bayer AG - R&D Expenditure, 2016-2018
Figure 8.13:    SWOT Analysis: Bayer AG
Figure 8.14:    BioElectronics Corporation: Overall Product Portfolio
Figure 8.15:    Bioelectronics Corporation - Overall Financials, 2015-2017
Figure 8.16:    Bioelectronics Corporation: R&D Expenditure, 2015-2017
Figure 8.17:    SWOT Analysis: Bioelectronics Corporation
Figure 8.18:    Boston Scientific Corporation: Overall Product Portfolio
Figure 8.19:    Boston Scientific Corporation: Overall Financials, 2016-2018
Figure 8.20:    Boston Scientific Corporation: Revenue (by Segment), 2016-2018
Figure 8.21:    Boston Scientific Corporation: Revenue (by Region), 2016-2018
Figure 8.22:    Boston Scientific Corporation: R&D Expenditure, 2016-2018
Figure 8.23:    SWOT Analysis: Boston scientific Corporation
Figure 8.24:    Medtronic Plc: Overall Product Portfolio
Figure 8.25:    Medtronic Plc: Overall Financials, 2016-2018
Figure 8.26:    Medtronic plc: Revenue (by Segment), 2016-2018
Figure 8.27:    Medtronic plc: Revenue (by Region), 2016-2018
Figure 8.28:    Medtronic Plc: R&D Expenditure, 2016-2018
Figure 8.29:    Medtronic plc: SWOT Analysis
Figure 8.30:    Koninklijke Philips N.V. - Product Portfolio for Global non-opioid pain relief device Market
Figure 8.31:    Koninklijke Philips N.V. - Overall Financials, 2016-2018
Figure 8.32:    Koninklijke Philips N.V. - Revenue (by Segment), 2016-2018
Figure 8.33:    Koninklijke Philips N.V. - Revenue (by Region), 2016-2018
Figure 8.34:    Koninklijke Philips N.V. - R&D Expenditure, 2016-2018
Figure 8.35:    SWOT Analysis - Koninklijke Philips N.V.
Figure 8.36:    NeuroMetrix, Inc.: Overall Product Portfolio
Figure 8.37:    Neurometrix Inc. - Overall Financials, 2016-2018
Figure 8.38:    Neurometrix Inc.: R&D Expenditure, 2016-2018
Figure 8.39:    SWOT Analysis: Neurometrix, Inc.
Figure 8.40:    Nuvectra Corporation: Overall Product Portfolio
Figure 8.41:    Neurometrix Inc. - Overall Financials, 2016-2018
Figure 8.42:    Nuvectra Corporation: Revenue by Segment, 2016-2018
Figure 8.43:    Nuvectra Corporation: Revenue by Region, 2016-2018
Figure 8.44:    Nuvectra Corporation R&D Expenditure, 2016-2018
Figure 8.45:    SWOT Analysis – Nuvectra Corporation
Figure 8.46:    Omron Corporation - Product Portfolio for Global non-opioid pain relief device Market
Figure 8.47:    Omron Corporation - Overall Financials, 2015-2017
Figure 8.48:    Omron Corporation: Revenue by Segment, 2015-2017
Figure 8.49:    Omron Corporation: Revenue by Region, 2015-2017
Figure 8.50:    Omron Corporation: R&D Expenditure, 2015-2017
Figure 8.51:    SWOT Analysis – Omron Corporation
Figure 8.52:    Stryker Corporation - Product Portfolio for global non-opioid pain relief device market Market
Figure 8.53:    Stryker Corporation - Overall Financials, 2016-2018
Figure 8.54:    Stryker Corporation: Revenue by Segment, 2016-2018
Figure 8.55:    Stryker Corporation - Revenue (by Region), 2016-2018
Figure 8.56:    Stryker Corporation R&D Expenditure, 2016-2018
Figure 8.57:    SWOT Analysis – Stryker Corporation
Figure 8.58:    SPR Therapeutics: Overall Product Portfolio
Figure 8.59:    SWOT Analysis – SPR Therapeutics
Figure 8.60:    Stimwave LLC: Overall Product Portfolio
Figure 8.61:    SWOT Analysis – Stimwave LLC
Figure 8.62:    Thermotek Inc.: Overall Product Portfolio
Figure 8.63:    SWOT Analysis – Thermotek Inc.
Figure 8.64:    Zynex Medical: Overall Product Portfolio
Figure 8.65:    Zynex Medical - Overall Financials, 2016-2018
Figure 8.66:    Zynex Medical R&D Expenditure, 2016-2018
Figure 8.67:    SWOT Analysis : Zynex Medical
Figure: 9.1:    Global Non-Opioid Pain Relief Device Market
Figure: 9.2:    Global Non- Opioid Pain Relief DeviceMarket: Research Methodology
Figure: 9.3:    Secondary Research
Figure: 9.4:    Data Triangulation
Figure: 9.5:    Bottom-Up Approach
Figure: 9.6:    Top-Down Approach
Figure: 9.7:    Considered Factors for Data Prediction and Modelling

We understand that your business need specific answers pertaining to the market. And , therefore, we do provide customised research tailored to your need.

With the purchase of this report, you are entitled to certain degree of free customisation within the scope of the study.

Do get in touch to help us understand how we can serve u better with a custom solution to your research needs. We assure quick turnaround for your pressing business requirements.

Contact Information


Name *
Email *
 
Company Name *
Designation*
 
 
Contact No. *
Other Details
 
 

Write the characters in the image above
 
 
* Required Fields

REQUEST SAMPLE   Schedule A Call
PLEASE SELECT A LICENSE TYPE
 
 
 

  REQUEST    SAMPLE   Schedule
    A Call

Key Questions Answered in this Report:

•    What are the major non-opioid pain relief devices available within the market and what are their benefits?
•    What are the major drivers, challenges, and opportunities in the global non-opioid pain relief device market? 
•    What are the key developmental strategies implemented by the key players to stand out in this market? 
•    How is the industry anticipated to evolve during the forecast period 2019-2029? 
•    Which region is expected to contribute to the highest sales of the global non-opioid pain relief device market during the forecast period? 
•    What are the leading trends and consumer preferences witnessed in global non-opioid pain relief device market?

Overview of the Global Non-Opioid Pain Relief Device Market

The rising trend of sedentary lifestyle and growing geriatric population have led to the emergence of chronic pain disorders. Multiple chronic pain conditions including neurological and musculoskeletal disorders act as leading contributors for the global non-opioid pain relief device market. These factors have become the primary drivers for the non-opioid pain relief device market. The market is further expected to proliferate at a rapid pace owing to the increased side effects of opioid medications for pain management, that further promote the early adoption of non-opioid pain relief medical devices among people of all age groups. Moreover, a limited success rate of drugs targeting a specific disease is further facilitating the growth of the market.

Global Non-Opioid Pain Relief Device Market Forecast (2019-2029)

In 2018, the global non-opioid pain relief device market was estimated to be $3,674 million and it is expected to reach a value of $8,778.9 million by the end of 2029. The market is primarily driven by increasing government regulations and higher incidences of chronic pain.

The overall global non-opioid pain relief device market has witnessed a steady growth. The market is expected to continue to grow with a CAGR of 8.26% during the forecast period 2019-2029. However, limited products available and limited awareness regarding them act as challenges that may affect the steady growth of the market

Expert Quote

“North America held the largest market share in 2018 and constitutes over 39.5% of the revenue share owing to increased incidences of chronic pain as well as higher proliferation of regulations and standards in different parts of the world. However, Asia-Pacific is projected to be the fastest-growing region and is anticipated to grow at a CAGR of over 9.9% from 2019 to 2029.”

Scope of the Global Non-Opioid Pain Relief Device Market Report

 

The report presents the reader with an opportunity to unlock comprehensive insights with respect to the market and uncover some of the substantial parameters that must be taken into consideration before entering the market.

The report further takes into consideration the market dynamics and the competitive landscape along with the detailed financial and product contribution of the key players operating in the market. The Global Non-Opioid Pain Relief Device Market report is a compilation of different segments including market breakdown by application, technology, end-user, and region. 

Market Segmentation

The global non-opioid pain relief device market segmentation is majorly done on the basis of application and technology. The application section was further segmented into neuromuscular, musculoskeletal, diabetic neuropathy, injuries and others. The neuromuscular segment dominated the global non-opioid pain relief device market, accounting for around 37.4% of the total market in 2018 and is anticipated to maintain its dominance throughout the forecast period. The other segments within the market are also estimated to witness steady growth rate in the forecast period due to surge in geriatric population worldwide and stringent regulations pertaining to opioid usage.

The global non-opioid pain relief device market segmentation is done on the basis of technology, and it is further segmented into Electroanalgesia, Radiofrequency Ablation and Other Emerging Technologies. The Electroanalgesia segment comprises multiple technologies and dominates the market with a share of 90.1%. The Radiofrequency ablation and other emerging technologies have a share of 9.7% and 0.2% respectively in the global non-opioid pain relief device market. The increased funding in research and development sector by leading companies and by government institutions have led to the advancement in the technologies and also in the associated market.

The global non-opioid pain relief device market segmentation by region is done into North America, Europe, APAC, Latin America and Middle East and Africa. North America dominated the global non-opioid pain relief device market accounting for 39.5% of the total market share in 2018 and is anticipated to uphold its dominance throughout the forecast period. The global non-opioid pain relief device market was estimated to have 1,452.6 million market in 2018. However, the highest growth rate of 9.9% is expected to be witnessed by the APAC region in the forecast period of 2019-2029. 

Key Companies in the Global Non-Opioid Pain Relief Device Market

The key players in the global non-opioid pain relief device market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Koninklijke Philips N.V., Stryker, Nuvectra Corporation, Omron Corporation, Neurometrix, Inc, Calmare Therapeutics Incorporated, Bayer AG, Bioelectronics Corporation, Zynex Medical, SPR Therapeutics, AAND Stimwave LLC, Thermotek Inc.

   Executive Summary
   1    Market Overview
         1.1    Pain Management Overview
         1.2    Pain Management by Usage of Opioid Drugs
         1.3    Pain Management by Usage of Non-Opioid Drugs and Devices
         1.4    Evolution of Pain Relief Devices
         1.5    Factors Propelling the Market Growth
         1.6    Classification of Non-Opioid Pain Relief Devices Market
         1.7    Potential Benefits and Risks of Non-Opioid Pain Relief Devices
         1.8    Market Limitations and Assumptions
 
   2    Market Dynamics
         2.1    Overview
         2.2    Market Drivers
                  2.2.1    Increase in Pain Incidences in Geriatric Population
                  2.2.2    Advent of Sedentary Lifestyle Leading to Increased Burden of Chronic Pain
                  2.2.3    Limited success Rate of Drugs Targeting Pain Disorders
                  2.2.4    High Number of Side Effects of the Opioid Drugs
         2.3    Market Restraints
                  2.3.1    Insufficient Number of Long-Term Clinical Studies
                  2.3.2    Low Number of Pain Specialists Worldwide
                  2.3.3    Burden of Product Recalls
                  2.3.4    Limited Awareness Regarding Products Available
         2.4    Market Trends
                  2.4.1    Shift of Demand Toward Wearable Technology
                  2.4.2    Miniaturization and Technological Advancement in the Pain Relief Technologies
                  2.4.3    Emergence of Minimally Invasive Therapies for Pain Relief
                  2.4.4    Non-Opioid Treatment for Pain Over Opioid Therapies
 
   3    Competitive Landscape
         3.1    Key Strategies and Developments
         3.2    Key Strategies and Developments
                  3.2.1    Product Launches
                  3.2.2    Collaborations, Joint Ventures, and Partnerships
                  3.2.3    Awards and Recognitions
                  3.2.4    Mergers and Acquisitions
         3.3    Market Share Analysis
                  3.3.1    Market Share Analysis (by Company)
         3.4    Market Share Analysis (by Country)
         3.5    Industry Attractiveness (Porter’s Five Forces Analysis)
                  3.5.1    Bargaining Power of Suppliers
                              3.5.1.1    Supplier to Firm Concentration Ratio
                              3.5.1.2    Presence of Brands
                              3.5.1.3    Degree of Product Differentiation
                              3.5.1.4    Threat of Forward Integration
                  3.5.2    Bargaining Power of Buyers
                              3.5.2.1    Buyer to Firm Concentration Ratio
                              3.5.2.2    Presence of Substitutes
                              3.5.2.3    Dependence on Distribution Channels
                              3.5.2.4    Buyer Information About Products
                  3.5.3    Threat of New Entrants
                              3.5.3.1    Regulatory Landscape
                              3.5.3.2    Brand Visibility
                              3.5.3.3    Product Differentiation
                              3.5.3.4    Capital Investments and Funding
                  3.5.4    Threat of Substitutes
                              3.5.4.1    Buyers’ Propensity toward Substitutes
                              3.5.4.2    Availability of Substitutes
                              3.5.4.3    Perceived Level of Product Differentiation
                   3.5.5    Intensity of Competitive Rivalry
                               3.5.5.1    Customer’s Loyalty Toward the Brand Image
                               3.5.5.2    Entry Barriers Through Innovations
                               3.5.5.3    Power of Competitive Strategy
         3.6    Industry Insights
                  3.6.1 Regulatory Organizations/ Associations/ Consortiums
 
   4    Global Non-Opioid Pain Relief Device Market (By Application)
         4.1    Overview
         4.2    Neuromuscular Pain
         4.3    Musculoskeletal Pain
         4.4    Injuries
         4.5    Diabetic Neuropathy
         4.6    Others
 
   5    Global Non-Opioid Pain Relief Device Market (by Technology)
         5.1    Overview
         5.2    Electroanalgesia
                  5.2.1    Implantable Device
                  5.2.2    Non-Implantable Device
                              5.2.2.1    Traditional TENS
                              5.2.2.2    Wearable TENS
                              5.2.2.3    Others
         5.3    Radiofrequency Ablation
         5.4    Other Emerging Technologies
 
   6    Global Non-Opioid Pain Relief Device Market (by End User)
         6.1    Overview
         6.2    Hospitals
         6.3    Pain Management Centers
         6.4    Homecare
 
   7    Global Non-Opioid Pain Relief Device Market (by Region)
         7.1    Overview
         7.2    North America Non-Opioid Pain Relief Device Market
                  7.2.1    North America Non-Opioid Pain Relief Device Market, 2018-2029, $Million
                  7.2.2    North America Non-Opioid Pain Relief Device Market (by Application),  2018-2029, $Million
                  7.2.3    North America Non-Opioid Pain Relief Device Market (by Technology), 2018-2029, $Million
                  7.2.4    North America Non-Opioid Pain Relief Device Market (by End User), 2018-2029, $Million
                  7.2.5    North America Non-Opioid Pain Relief Device Market (by Country), 2018-2029, $Million
                  7.2.6    North America Non-Opioid Pain Relief Device Market (by Country), 2018-2029, $Million
                              7.2.6.1    The U.S.
                              7.2.6.2    Canada
         7.3    Europe Non-Opioid Pain Relief Device Market
                  7.3.1    Europe Non-Opioid Pain Relief Device Market, 2018-2029, $Million
                  7.3.2    Europe Non-Opioid Pain Relief Device Market (by Application), 2018-2029, $Million
                  7.3.3    Europe Non-Opioid Pain Relief Device Market (by Technology), 2018-2029, $Million
                  7.3.4    Europe Non-Opioid Pain Relief Device Market (by Country), 2018-2029, $Million
                              7.3.4.1    The U.K.
                              7.3.4.2    Germany
                              7.3.4.3    Italy
                              7.3.4.4    France
                              7.3.4.5    Netherlands
                              7.3.4.6    Spain
                              7.3.4.7    Rest of Europe
         7.4    Asia Pacific Non-Opioid Pain Relief Device Market
                  7.4.1    Asia-Pacific Non-Opioid Pain Relief Device Market, 2018-2029, $Million
                  7.4.2    Asia-Pacific Non-Opioid Pain Relief Device Market (by Application), 2018-2029, $Million
                  7.4.3    Asia-Pacific Non-Opioid Pain Relief Device Market (by Technology), 2018-2029, $Million
                  7.4.4    Asia-Pacific Non-Opioid Pain Relief Device Market (by Country), 2018-2029, $Million
                              7.4.4.1    China
                              7.4.4.2    India
                              7.4.4.3    Japan
                              7.4.4.4    Australia
                              7.4.4.5    New Zealand
                              7.4.4.6    Rest-of-Asia-Pacific
         7.5    Latin America Non-Opioid Pain Relief Device Market
                  7.5.1    Latin America Non-Opioid Pain Relief Device Market, 2018-2029, $Million
                  7.5.2    Latin America Non-Opioid Pain Relief Device Market (By Application), 2018-2029, $Million
                  7.5.3    Latin America Non-Opioid Pain Relief Device Market (By Technology), 2018-2029, $Million
                  7.5.4    Latin America Non-Opioid Pain Relief Device Market (by End User), 2018-2029, $Million
                  7.5.5    Latin America Non-Opioid Pain Relief Device Market (by Country),  2018-2029, $Million
                              7.5.5.1    Brazil
                              7.5.5.2    Mexico
                              7.5.5.3    Rest-of-Latin America
         7.6    Middle East and Africa Non-Opioid Pain Relief Device Market, 2018-2029, $Million
                  7.6.1    Middle East and Africa Non-Opioid Pain Relief Device Market, 2018-2029, $Million
                  7.6.2    Middle East and Africa Non-Opioid Pain Relief Device Market (By Application), 2018-2029, $Million
                  7.6.3    Middle East and Africa Non-Opioid Pain Relief Device Market (By Technology), 2018-2029, $Million
                  7.6.4    Middle East and Africa Non-Opioid Pain Relief Device Market (by End User), 2018-2029, $Million
                  7.6.5    Middle East and Africa Non-Opioid Pain Relief Device Market (By Country), 2018-2029, $Million
                              7.6.5.1    Kingdom of Saudi Arabia
                              7.6.5.2    South Africa
                              7.6.5.3    Rest-of-Middle East and Africa
 
   8    Company Profiles
         8.1    Overview
         8.2    Abbott Laboratories
                  8.2.1    Company Overview
                  8.2.2    Role of Abbott Laboratories in the Global Non-Opioid Pain Relief Devices Market
                  8.2.3    Financials
                  8.2.4    SWOT Analysis
         8.3    Bayer AG
                  8.3.1    Company Overview
                  8.3.2    Role of Bayer AG in the Global Non-opioid pain relief device Market
                  8.3.3    Financials
                  8.3.4    SWOT Analysis
         8.4    Bioelectronics Corporation
                  8.4.1    Company Overview
                  8.4.2    Role of Bioelectronics Corporation in the Global Non-Opioid Pain Relief Devices Market
                  8.4.3    Financials
                  8.4.4    SWOT Analysis
         8.5    Boston Scientific Corporation
                  8.5.1    Company Overview
                  8.5.2    Financials
                  8.5.3    SWOT Analysis
         8.6    Medtronic plc
                  8.6.1    Company Overview
                  8.6.2    Role of Medtronic plc in the Non-Opioid Pain Relief Devices Market
                  8.6.3    Financials
                  8.6.4    Key Insights about Financial Health of the Company
                  8.6.5    SWOT Analysis
         8.7    Koninklijke Philips N.V.
                  8.7.1    Company Overview
                  8.7.2    Role of Koninklijke Philips N.V. in the Global non-opioid pain relief device Market
                  8.7.3    Financials
                  8.7.4    SWOT Analysis
         8.8    NeuroMetrix Inc.
                  8.8.1    Company Overview
                  8.8.2    Role of NeuroMetrix, Inc. in the Non-Opioid Pain Relief Devices Market
                  8.8.3    Financials
                  8.8.4    SWOT Analysis
         8.9    Nuvectra Corporation
                  8.9.1    Company Overview
                  8.9.2    Role of Nuvectra Corporation in the Global Non-Opioid Pain relief Device Market
                  8.9.3    Financials
                  8.9.4    SWOT Analysis
        8.10   Omron Corporation
                  8.10.1    Company Overview
                  8.10.2    Role of Omron Corporation in the Global Non-Opioid Pain Relief Device Market
                  8.10.3    Financials
                  8.10.4    SWOT Analysis
        8.11   Stryker Corporation
                  8.11.1    Company Overview
                  8.11.2    Role of Stryker Corporation in the Global Non-Opioid Pain Relief Device Market
                  8.11.3    Financials
                  8.11.4    SWOT Analysis
        8.12   SPR Therapeutics, LLC
                  8.12.1    Company Overview
                  8.12.2    Role of SPR Therapeutics, LLC in the Global Non-Opioid Device Market
                  8.12.3    SWOT Analysis
        8.13   Stimwave LLC
                  8.13.1    Company Overview
                  8.13.2    Role of Stimwave LLC in the Global Non-Opioid Device Market
                  8.13.3    SWOT Analysis
        8.14   Thermotek Inc.
                  8.14.1    Company Overview
                  8.14.2    Role of Thermotek Inc. in the Global Non-Opioid Device Market
                  8.14.3    SWOT Analysis
        8.15   Zynex Medical
                  8.15.1    Company Overview
                  8.15.2    Role of Zynex Medical in the Global Non-Opioid Device Market
                  8.15.3    Financials
                  8.15.4    SWOT Analysis
 
   9    Research Scope and Methodology
         9.1    Report Scope
         9.2    Global Non-Opioid Pain Relief Device Market: Research Methodology
                  9.2.1    Primary Data Sources
                  9.2.2    Secondary Data Sources
                  9.2.3    Data Triangulation
         9.3    Data and Prediction Modeling
 

List of Tables

Table 1:    Impact of Market Drivers, 2018-2029
Table 2:    Impact of Market Restraints, 2018-2029
Table 1.1:    List of Non-Opioids Pain Relief Drugs*
Table 1.2:    List of Non-Opioid Pain Relief Medical Devices*
Table 2.1:    Global Mortality Census Post Opioid Usage Disorder (Year – 2015)
Table 2.2:    Market Drivers: Impact Analysis
Table 2.3:    Market Restraints: Impact Analysis
Table 3.1:    Regulatory Bodies Related to Non-Opioid Pain Relief Devices (by Country)

List of Figures

Figure 1:    Global Non-Opioid Pain Relief Device Market (by Application), 2018 and 2029
Figure 2:    Global Non-Opioid Pain Relief Device Market (by Technology), 2018 and 2029
Figure 3:    Global Non-Opioid Pain Relief Device Market (by End User), 2018 and 2029
Figure 4:    Global Non-Opioid Pain Relief Device Market (by Region), 2019- 2029
Figure 5:    Key Strategies Incorporated by the key Players in the Global Non-Opioid Pain Relief Device Market (January 2019 – April 2029)
Figure 6:    Market Share Analysis for the Global Non-Opioid Pain Relief Device Market (by Company) (2018)
Figure 1.1:    Global Non-Opioid Pain Relief Device Market, 2018-2029, $Million
Figure 2.1:    Global Non-Opioid Pain Relief Device Market Dynamics
Figure 3.1:    Share of Key Developments and Strategies, January 2016 -February 2019
Figure 3.2:    Product Launches (by Company), January 2017-February 2019
Figure 3.3:    Collaborations and Partnerships (by Company), January 2015-February 2019
Figure 3.4:    Awards and Recognition (by Company), January 2015-February 2019
Figure 3.5:    Mergers and Acquisitions Share (by Company), January 2015-February 2019
Figure 3.6:    Market Share Analysis for the Global Non-Opioid Pain Relief Device Market, by Company (2018)
Figure 3.7:    Market Share Analysis for the Global Non-Opioid Pain Relief Device Market (by Country) (2018 and 2029)
Figure 3.8:    Industry Attractiveness (Porter’s Five Forces Analysis)
Figure 3.9:    Analysis of Bargaining Power of Suppliers, 2018 and 2029
Figure 3.10    : Analysis of Bargaining Power of Buyers, 2018 and 2029
Figure 3.11    : Analysis of Threat of New Entrants, 2018 and 2029
Figure 3.12    : Analysis of Threat of Substitutes, 2018 and 2029
Figure 3.13    : Analysis of Intensity of Competitive Rivalry, 2018 and 2029
Figure 4.1:    Global Non-Opioid Pain Relief Device Market (By Application), 2018-2029, $Million
Figure 4.2:    Global Non-Opioid Pain Relief Device Market (Neuromuscular Pain), 2018-2029, $Million
Figure 4.3:    Global Non-Opioid Pain Relief Device Market (Musculoskeletal Pain), 2018-2029, $Million
Figure 4.4:    Global Non-Opioid Pain Relief Device Market (Injuries), 2018-2029, $Million
Figure 4.5:    Global Non-Opioid Pain Relief Device Market (Diabetic Neuropathy), 2018-2029, $Million
Figure 4.6:    Global Non-Opioid Pain Relief Device Market (Other Pain), 2018-2029, $Million
Figure 5.1:    Global Non-Opioid Pain Relief Device Market (by Technology), 2018-2029, $Million
Figure 5.2:    Global Non-Opioid Pain Relief Device Market (Electroanalgesia), 2018-2029, $Million
Figure 5.3:    Global Non-Opioid Pain Relief Device Market (By Electroanalgesia Technology), 2018 and 2029
Figure 5.4:    Global Non-Opioid Pain Relief Device Market (Implantable Device), 2018-2029, $Million
Figure 5.5:    Market Share Analysis of Key Players in the Implantable Pain Relief Device Market, $Million
Figure 5.6:    Fragmentation of Non-Implantable Electroanalgesia Technologies- TENS, 2018 and 2029
Figure 5.7:    Global Non-Opioid Pain Relief Device Market (Traditional TENS), 2018-2029, $Million
Figure 5.8:    Market Share Analysis of Key Players in the Traditional TENS Device Market, $Million
Figure 5.9:    Global Non-Opioid Pain Relief Device Market (Wearable TENS), 2018-2029, $Million
Figure 5.10:    Market Share Analysis of Key Players in the Wearable TENS Device Market, $Million
Figure 5.11:    Global Non-Opioid Pain Relief Device Market (Others), 2018-2029, $Million
Figure 5.12:    Global Non-Opioid Pain Relief Device Market (Radiofrequency Ablation), 2018-2029, $Million
Figure 5.13:    Market Share Analysis of Key Players in Radiofrequency Ablation Device Market, $Million
Figure 5.14:    Global Non-Opioid Pain Relief Device Market (Other Emerging Technologies), 2018-2029, $Million
Figure 6.1:    Global Non-Opioid Pain Relief Device Market (by End User), 2018-2029, $Million
Figure 6.2:    Global Non-Opioid Pain Relief Devices Market (by Hospitals), 2018-2029, $Million
Figure 6.3:    Global Non-Opioid Pain Relief Devices Market (by Pain Management Centres), 2018-2029, $Million
Figure 6.4:    Global Non-Opioid Pain Relief Devices Market (by Homecare), 2018-2029, $Million
Figure 7.1:    Global Non-Opioid Pain Relief Device Market Scenario (by Region), 2018 and 2029, $Million
Figure 7.2:    North America Non-Opioid Pain Relief Device Market Scenario, 2018-2029, $Million
Figure 7.3:    North America Non-Opioid Pain Relief Device Market Scenario (By Application), 2018 and 2029, $Million
Figure 7.4:    North America Non-Opioid Pain Relief Device Market Scenario (by Application), 2018 and 2029, $Million
Figure 7.5:    North America Non-Opioid Pain Relief Device Market Scenario (by End User), 2018 and 2029, $Million
Figure 7.6:    North America Non-Opioid Pain Relief Device Market Scenario (by Country), 2018 and 2029, $Million
Figure 7.7:    U.S. Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
Figure 7.8:    Canada Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
Figure 7.9:    Europe Non-Opioid Pain Relief Device Market Scenario, 2018 and 2029, $Million
Figure 7.10:    Europe Non-Opioid Pain Relief Device Market, (By Application), 2018 and 2029, $Million
Figure 7.11:    Europe Non-Opioid Pain Relief Device Market Scenario (By Technology), 2018 and 2029, $Million
Figure 7.12:    Europe Non-Opioid Pain Relief Device Market Scenario (by Country), 2018 and 2029, $Million
Figure 7.13:    The U.K. - Non-Opioid Pain Relief Device Market, 2018-2029, $Million
Figure 7.14:    Germany- Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
Figure 7.15:    Italy-Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
Figure 7.16:    France- Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
Figure 7.17:    Netherlands- Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
Figure 7.18:    Spain- Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
Figure 7.19:    Rest of Europe Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
Figure 7.20:    Asia-Pacific Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
Figure 7.21:    Asia-Pacific Non-Opioid Pain Relief Device Market Scenario (by Application), 2018 and 2029, $Million
Figure 7.22:    Asia-Pacific Non-Opioid Pain Relief Device Market Scenario (by Technology), 2018 and 2029, $Million
Figure 7.23:    Asia-Pacific Non-Opioid Pain Relief Device Market Scenario (by Country), 2018 and 2029, $Million
Figure 7.24:    China Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
Figure 7.25:    India Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
Figure 7.26:    Japan Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
Figure 7.27:    Australia Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
Figure 7.28:    New Zealand Non-Opioid Pain Relief Device Market, 2018-2029, $Million
Figure 7.29:    Rest-of-Asia-Pacific Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
Figure 7.30:    Latin America Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
Figure 7.31:    Latin America Non-Opioid Pain Relief Device Market Scenario (by Application), 2018 and 2029, $Million
Figure 7.32:    Latin America Non-Opioid Pain Relief Device Market (by Technology), 2018 and 2029, $Million
Figure 7.33:    Latin America Non-Opioid Pain Relief Device Market (by End User), 2018 and 2029, $Million
Figure 7.34:    Latin America Non-Opioid Pain Relief Device Market (By Country), 2018 and 2029, $Million
Figure 7.35:    Brazil Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
Figure 7.36:    Mexico Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
Figure 7.37:    Rest-of-Latin America Non-Opioid Pain Relief Device Market,  2018- 2029, $Million
Figure 7.38:    Middle East and Africa Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
Figure 7.39:    Middle East and Africa Non-Opioid Pain Relief Device Market (By Application), 2018 and 2029, $Million
Figure 7.40:    Middle East and Africa Non-Opioid Pain Relief Device Market Scenario (By Technology), 2018 and 2029, $Million
Figure 7.41:    Middle East and Africa Non-Opioid Pain Relief Device Market (By End-user), 2018 and 2029, $Million
Figure 7.42:    Middle East and Africa Non-Opioid Pain Relief Device Market (by Country), 2018 and 2029, $Million
Figure 7.43:    Kingdom of Saudi Arabia Non-Opioid Pain Relief Device Market, 2018 and 2029, $Million
Figure 7.44:    South Africa Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
Figure 7.45:    South Africa Non-Opioid Pain Relief Device Market, 2018- 2029, $Million
Figure 8.1:    Total Number of Companies Profiled
Figure 8.2:    Abbott Laboratories: Overall Product Portfolio for Global Non-opioid Pain Relief Device Market
Figure 8.3:    Abbott Laboratories: Overall Financials, 2016-2018
Figure 8.4:    Abbott Laboratories: Revenue (by Segment), 2016-2018
Figure 8.5:    Abbott Laboratories: Revenue (by Region), 2016-2018
Figure 8.6:    Abbott Laboratories: R&D Expenditure, 2016-2018
Figure 8.7:    Abbott Laboratories: SWOT Analysis
Figure 8.8:    Bayer AG - Product Portfolio for Global Non-Opioid Pain Relief Device Market
Figure 8.9:    Bayer AG - Overall Financials, 2016-2018
Figure 8.10:    Bayer AG - Revenue (by Segment), 2016-2018
Figure 8.11:    Bayer AG - Revenue (by Region), 2016-2018
Figure 8.12:    Bayer AG - R&D Expenditure, 2016-2018
Figure 8.13:    SWOT Analysis: Bayer AG
Figure 8.14:    BioElectronics Corporation: Overall Product Portfolio
Figure 8.15:    Bioelectronics Corporation - Overall Financials, 2015-2017
Figure 8.16:    Bioelectronics Corporation: R&D Expenditure, 2015-2017
Figure 8.17:    SWOT Analysis: Bioelectronics Corporation
Figure 8.18:    Boston Scientific Corporation: Overall Product Portfolio
Figure 8.19:    Boston Scientific Corporation: Overall Financials, 2016-2018
Figure 8.20:    Boston Scientific Corporation: Revenue (by Segment), 2016-2018
Figure 8.21:    Boston Scientific Corporation: Revenue (by Region), 2016-2018
Figure 8.22:    Boston Scientific Corporation: R&D Expenditure, 2016-2018
Figure 8.23:    SWOT Analysis: Boston scientific Corporation
Figure 8.24:    Medtronic Plc: Overall Product Portfolio
Figure 8.25:    Medtronic Plc: Overall Financials, 2016-2018
Figure 8.26:    Medtronic plc: Revenue (by Segment), 2016-2018
Figure 8.27:    Medtronic plc: Revenue (by Region), 2016-2018
Figure 8.28:    Medtronic Plc: R&D Expenditure, 2016-2018
Figure 8.29:    Medtronic plc: SWOT Analysis
Figure 8.30:    Koninklijke Philips N.V. - Product Portfolio for Global non-opioid pain relief device Market
Figure 8.31:    Koninklijke Philips N.V. - Overall Financials, 2016-2018
Figure 8.32:    Koninklijke Philips N.V. - Revenue (by Segment), 2016-2018
Figure 8.33:    Koninklijke Philips N.V. - Revenue (by Region), 2016-2018
Figure 8.34:    Koninklijke Philips N.V. - R&D Expenditure, 2016-2018
Figure 8.35:    SWOT Analysis - Koninklijke Philips N.V.
Figure 8.36:    NeuroMetrix, Inc.: Overall Product Portfolio
Figure 8.37:    Neurometrix Inc. - Overall Financials, 2016-2018
Figure 8.38:    Neurometrix Inc.: R&D Expenditure, 2016-2018
Figure 8.39:    SWOT Analysis: Neurometrix, Inc.
Figure 8.40:    Nuvectra Corporation: Overall Product Portfolio
Figure 8.41:    Neurometrix Inc. - Overall Financials, 2016-2018
Figure 8.42:    Nuvectra Corporation: Revenue by Segment, 2016-2018
Figure 8.43:    Nuvectra Corporation: Revenue by Region, 2016-2018
Figure 8.44:    Nuvectra Corporation R&D Expenditure, 2016-2018
Figure 8.45:    SWOT Analysis – Nuvectra Corporation
Figure 8.46:    Omron Corporation - Product Portfolio for Global non-opioid pain relief device Market
Figure 8.47:    Omron Corporation - Overall Financials, 2015-2017
Figure 8.48:    Omron Corporation: Revenue by Segment, 2015-2017
Figure 8.49:    Omron Corporation: Revenue by Region, 2015-2017
Figure 8.50:    Omron Corporation: R&D Expenditure, 2015-2017
Figure 8.51:    SWOT Analysis – Omron Corporation
Figure 8.52:    Stryker Corporation - Product Portfolio for global non-opioid pain relief device market Market
Figure 8.53:    Stryker Corporation - Overall Financials, 2016-2018
Figure 8.54:    Stryker Corporation: Revenue by Segment, 2016-2018
Figure 8.55:    Stryker Corporation - Revenue (by Region), 2016-2018
Figure 8.56:    Stryker Corporation R&D Expenditure, 2016-2018
Figure 8.57:    SWOT Analysis – Stryker Corporation
Figure 8.58:    SPR Therapeutics: Overall Product Portfolio
Figure 8.59:    SWOT Analysis – SPR Therapeutics
Figure 8.60:    Stimwave LLC: Overall Product Portfolio
Figure 8.61:    SWOT Analysis – Stimwave LLC
Figure 8.62:    Thermotek Inc.: Overall Product Portfolio
Figure 8.63:    SWOT Analysis – Thermotek Inc.
Figure 8.64:    Zynex Medical: Overall Product Portfolio
Figure 8.65:    Zynex Medical - Overall Financials, 2016-2018
Figure 8.66:    Zynex Medical R&D Expenditure, 2016-2018
Figure 8.67:    SWOT Analysis : Zynex Medical
Figure: 9.1:    Global Non-Opioid Pain Relief Device Market
Figure: 9.2:    Global Non- Opioid Pain Relief DeviceMarket: Research Methodology
Figure: 9.3:    Secondary Research
Figure: 9.4:    Data Triangulation
Figure: 9.5:    Bottom-Up Approach
Figure: 9.6:    Top-Down Approach
Figure: 9.7:    Considered Factors for Data Prediction and Modelling

We understand that your business need specific answers pertaining to the market. And , therefore, we do provide customised research tailored to your need.

With the purchase of this report, you are entitled to certain degree of free customisation within the scope of the study.

Do get in touch to help us understand how we can serve u better with a custom solution to your research needs. We assure quick turnaround for your pressing business requirements.

Contact Information


Name *
Work Email *
 
Company Name *
Designation*
 
 
Contact No. *
Other Details
 
 

Write the characters in the image above
 
 
* Required Fields

Get yourself updated on key emerging technology markets

Know about our market intelligence coverage in key sectors